Effect of different obesogenic diets on pancreatic histology in Ossabaw miniature swine. 2011

Allison M Fullenkamp, and Lauren N Bell, and Reiesha D Robbins, and Lydia Lee, and Romil Saxena, and Mouhamad Alloosh, and James E Klaunig, and Raghavendra G Mirmira, and Michael Sturek, and Naga Chalasani
Indiana University School of Medicine, Indianapolis, IN, USA.

OBJECTIVE Obesity is a factor in the outcome and severity of pancreatic conditions. We examined the effect of hypercaloric diets on the pancreata of Ossabaw swine, a large animal model of metabolic syndrome and obesity. METHODS Swine were fed with 1 of 4 diets: high-fructose (n = 9), atherogenic (n = 10), modified atherogenic (n = 6), or eucaloric standard diet (n = 12) for 24 weeks. Serum chemistries were measured, and pancreata were examined for histological abnormalities including steatosis, inflammation or fibrosis, insulin content, and oxidative stress. RESULTS The fructose, atherogenic, and modified atherogenic diet groups exhibited obesity, metabolic syndrome, islet enlargement, and significantly increased pancreatic steatosis (22.9% ± 7.5%, 19.7% ± 7.7%, and 38.7% ± 15.3% fat in total tissue area, respectively) compared with controls (9.3% ± 1.9%; P < 0.05). The modified atherogenic diet group showed significantly increased oxidative stress levels as evidenced by elevated serum malondialdehyde (3.0 ± 3.3 vs 1.5 ± 0.3 μmol/L in controls; P = 0.006) and pancreatic malondialdehyde (0.1 ± 0.12 vs 0.04 ± 0.01 nmol/mg protein in controls; P = 0.01). None of the swine exhibited pancreatitis or cellular injury. CONCLUSIONS Ossabaw swine fed with a modified atherogenic diet developed significant pancreatic steatosis and increased oxidative stress, but no other histological abnormalities were observed.

UI MeSH Term Description Entries
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D002149 Energy Intake Total number of calories taken in daily whether ingested or by parenteral routes. Caloric Intake,Calorie Intake,Intake, Calorie,Intake, Energy
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004036 Diet, Atherogenic A diet that contributes to the development and acceleration of ATHEROGENESIS. Atherogenic Diet,Atherogenic Diets,Diets, Atherogenic
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005632 Fructose A monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding. Levulose,Apir Levulosa,Fleboplast Levulosa,Levulosa,Levulosa Baxter,Levulosa Braun,Levulosa Grifols,Levulosa Ibys,Levulosa Ife,Levulosa Mein,Levulosado Bieffe Medit,Levulosado Braun,Levulosado Vitulia,Plast Apyr Levulosa Mein,Levulosa, Apir,Levulosa, Fleboplast
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty

Related Publications

Allison M Fullenkamp, and Lauren N Bell, and Reiesha D Robbins, and Lydia Lee, and Romil Saxena, and Mouhamad Alloosh, and James E Klaunig, and Raghavendra G Mirmira, and Michael Sturek, and Naga Chalasani
April 2019, Comparative medicine,
Allison M Fullenkamp, and Lauren N Bell, and Reiesha D Robbins, and Lydia Lee, and Romil Saxena, and Mouhamad Alloosh, and James E Klaunig, and Raghavendra G Mirmira, and Michael Sturek, and Naga Chalasani
May 2011, American journal of physiology. Endocrinology and metabolism,
Allison M Fullenkamp, and Lauren N Bell, and Reiesha D Robbins, and Lydia Lee, and Romil Saxena, and Mouhamad Alloosh, and James E Klaunig, and Raghavendra G Mirmira, and Michael Sturek, and Naga Chalasani
August 2015, Journal of the American Heart Association,
Allison M Fullenkamp, and Lauren N Bell, and Reiesha D Robbins, and Lydia Lee, and Romil Saxena, and Mouhamad Alloosh, and James E Klaunig, and Raghavendra G Mirmira, and Michael Sturek, and Naga Chalasani
December 2010, The Journal of pharmacology and experimental therapeutics,
Allison M Fullenkamp, and Lauren N Bell, and Reiesha D Robbins, and Lydia Lee, and Romil Saxena, and Mouhamad Alloosh, and James E Klaunig, and Raghavendra G Mirmira, and Michael Sturek, and Naga Chalasani
March 2015, International journal of cardiology. Heart & vasculature,
Allison M Fullenkamp, and Lauren N Bell, and Reiesha D Robbins, and Lydia Lee, and Romil Saxena, and Mouhamad Alloosh, and James E Klaunig, and Raghavendra G Mirmira, and Michael Sturek, and Naga Chalasani
July 2009, Hepatology (Baltimore, Md.),
Allison M Fullenkamp, and Lauren N Bell, and Reiesha D Robbins, and Lydia Lee, and Romil Saxena, and Mouhamad Alloosh, and James E Klaunig, and Raghavendra G Mirmira, and Michael Sturek, and Naga Chalasani
June 2016, Data in brief,
Allison M Fullenkamp, and Lauren N Bell, and Reiesha D Robbins, and Lydia Lee, and Romil Saxena, and Mouhamad Alloosh, and James E Klaunig, and Raghavendra G Mirmira, and Michael Sturek, and Naga Chalasani
January 2014, Journal of diabetes research,
Allison M Fullenkamp, and Lauren N Bell, and Reiesha D Robbins, and Lydia Lee, and Romil Saxena, and Mouhamad Alloosh, and James E Klaunig, and Raghavendra G Mirmira, and Michael Sturek, and Naga Chalasani
February 2008, Coronary artery disease,
Allison M Fullenkamp, and Lauren N Bell, and Reiesha D Robbins, and Lydia Lee, and Romil Saxena, and Mouhamad Alloosh, and James E Klaunig, and Raghavendra G Mirmira, and Michael Sturek, and Naga Chalasani
June 2008, Coronary artery disease,
Copied contents to your clipboard!